Prenatal diagnosis of recurrent autosomal dominant osteogenesis imperfecta associated with unaffected parents and paternal gonadal mosaicism  by Chen, Chih-Ping et al.
Available online at www.sciencedirect.comTaiwanese Journal of Obstetrics & Gynecology 52 (2013) 106e109
www.tjog-online.comShort Communication
Prenatal diagnosis of recurrent autosomal dominant osteogenesis imperfecta
associated with unaffected parents and paternal gonadal mosaicism
Chih-Ping Chen a,b,c,d,e,f,g,*, Shuan-Pei Lin b,c,h,i, Yi-Ning Su j, Schu-Rern Chern b,
Jun-Wei Su a,k, Wayseen Wang b,l
aDepartment of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
bDepartment of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
cDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan
dDepartment of Biotechnology, Asia University, Taichung, Taiwan
e School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan
f Institute of Clinical and Community Health Nursing, National Yang-Ming University, Taipei, Taiwan
gDepartment of Obstetrics and Gynecology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
hDepartment of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan
iMackay Medicine, Nursing and Management College, Taipei, Taiwan
jDepartment of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
kDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan
lDepartment of Bioengineering, Tatung University, Taipei, Taiwan
Accepted 4 December 2012AbstractObjective: To present the prenatal diagnosis of recurrent autosomal dominant osteogenesis imperfecta (OI) associated with unaffected parents
and paternal gonadal mosaicism.
Materials and Methods: A 37-year-old woman was referred for genetic counseling at 18 weeks of gestation because of advanced maternal age
and a family history of OI. The woman had a daughter who was affected with OI type III and carried an insertion frameshift mutation of
c.4308_4309insA in exon 52 of the COL1A1 gene. The woman and her husband were non-consanguineous and healthy. Amniocentesis was
performed at 18 weeks of gestation.
Results: Cytogenetic analysis revealed a karyotype of 46,XX. Molecular analysis of the amniocytes revealed a recurrent mutation of
c.4308_4309insA in exon 52 of the COL1A1 gene. Mutational analysis of the family revealed no mutation of the COL1A1 gene in the parental
bloods. However, mosaicism for the COL1A1 mutation was found in the paternal sperms. Level II ultrasound examination showed a curved right
tibia, a narrow chest with irregular ribs and mild frontal bossing in the fetus. The parents decided to terminate the pregnancy, and a female fetus
was delivered at 23 weeks of gestation with curved long bones.
Conclusion: Recurrent autosomal dominant OI may occur in the offspring of unaffected parents with parental gonadal mosaicism. Genetic
counseling of recurrent autosomal dominant OI should include a thorough mutational analysis of the family members, and mutational analysis of
the sperm may detect paternal gonadal mosaicism for the mutation.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Fig. 1. Molecular analysis of the affected daughter shows an insertion fra-
meshift mutation of c.4308_4309insA in exon 52 of the COL1A1 gene.
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tissue manifestations such as blue sclerae, hyperlaxity of
skin and ligaments, dentinogenesis imperfecta (DI), and
hearing loss [1,2]. OI occurs in approximately
1:20,000e1:60,000 births [3,4]. Here, we report the identifi-
cation of an insertion frameshift mutation of c.4308_4309insA
in exon 52 of the COL1A1 gene in an 18-month-old girl with
OI type III and in a fetus with recurrent autosomal dominant
OI in a family with unaffected parents and paternal gonadal
mosaicism.
Materials and methods
A 37-year-old, gravida 4, para 3, woman was referred for
genetic counseling at 18 weeks of gestation because of
advanced maternal age and a family history of having
a daughter affected with OI type III. The 18-month-old
daughter was the woman’s second child of her second mar-
riage with a 44-year-old husband. The woman and her husband
were nonconsanguineous and healthy. The couple’s eldest 3-
year-old son was healthy. The mother’s other two children
of the previous marriage were all healthy. Their affected
daughter was delivered vaginally at 38 weeks of gestation after
an uncomplicated pregnancy, with a body weight of 2800 g
(15th centile) and a length of 48.5 cm (15th centile). Prenatal
ultrasound findings were unremarkable. Immediately after
birth, she was noted to have paralysis of the upper limbs.
Shoulder dislocation or subluxation, birth trauma of the bones,
brachial plexus injury and clavicle fractures were all sus-
pected. During admission, X-rays showed healed fractures in
the right humerus, left ulna and radius, bilateral femurs and
bilateral ribs, and a new fracture in the left humerus. Her
condition stabilized after parenteral bisphosphonate therapy.
Over the next 18 months, she suffered from repeated fractures
of the extremities after minimal traumas. The clinical findings
were consistent with the diagnosis of OI type III.
Results
On examination, she had mild scoliosis, blue sclerae and
DI, but no hearing loss. Molecular analysis of type I collagen
genes revealed an insertion frameshift mutation of
c.4308_4309insA in exon 52 of the COL1A1 gene (Fig. 1).
During this pregnancy, amniocentesis was performed at 18
weeks of gestation. Cytogenetic analysis of the amniocytes
revealed a karyotype of 46,XX. Molecular analysis of the
amniocytes revealed a recurrent mutation of c.4308_4309insA
in exon 52 of the COL1A1 gene (Fig. 2). Mutational analysis
of the parental bloods did not find such a mutation (Fig. 2).
However, molecular analysis of the sperm DNA derived from
the father revealed mosaicism for a mutation of
c.4308_4309insA in exon 52 of the COL1A1 gene (Fig. 2).
Level II ultrasound examination of the fetus showed a curved
right tibia, a narrow chest with irregular ribs and mild frontal
bossing. The parents decided to terminate the pregnancy, and
a 624 g female fetus was delivered, at 23 weeks of gestation,
with curved long bones.Discussion
To date, at least 12 types of OI have been identified, and
approximately 90% of the patients of OI have dominant mu-
tations in the COL1A1 gene (OMIM 120150) encoding a1
type I collagen chain and in the COL1A2 gene (OMIM
120160) encoding a2 type I collagen chain [5]. OI type I is
associated with mutations in COL1A1, mostly because of
a null allele caused by a premature stop codon due to de-
letions, duplications, nonsense mutations and frameshift mu-
tations [6,7]. OI type II w type IV are associated with
mutations in COL1A1 or COL1A2, most commonly due to
glycine substitutions and less frequently due to splicing de-
fects, deletions, insertions or duplications [8e11]. OI type Iw
type Vare inherited in an autosomal dominant pattern. OI type
VIw type XII are inherited in an autosomal recessive pattern
and can be caused by homozygous or compound heterozygous
mutations in the genes of FKBP10, CRTAP, LEPRE1, PPIB,
SERPINH2, SP7, and SERPINF1, respectively.
The present case provides evidence that an insertion muta-
tion of c.4308_4309insA in exon 52 of the COL1A1 gene can
result in OI, but not a lethal outcome. This insertion mutation
causes a frameshift and predicts p.Leu1437Thrfs*114, with
a substitution of leucine to threonine at 1437, an additional 85
amino acids, and a stop at the frameshift 114th codon. Such
a mutation is novel and has not previously been described.
OI cases with mutations in exon 52 near the carboxyl-
terminal propeptide region of COL1A1 have been
Fig. 2. Molecular analysis of the parental bloods, paternal sperms and
amniocytes. The amniocytes have an insertion frameshift mutation of
c.4308_4309insA in exon 52 of the COL1A1 gene. The sperms have mosai-
cism for the mutation. The parental bloods do not have such a mutation.
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have been reported according to the OI variant database [12].
These mutations include: (1) c.4257C>T, substitution, silent
mutation; (2) c.4292C>T, substitution, missense mutation,
p.Thr1431Ile, OI type IV; (3) c.4310T>A, substitution,
missense mutation, p.Leu1437Gln, OI type II; (4)
c.4321G>C, substitution, missense mutation, p.Asp1441His,
OI type I; (5) c.4321G>T, substitution, missense
mutation, p.Asp1441Tyr, OI type II; (6) c.4329_4340delin-
sAGACCAGGTC, insertion/deletion, frameshift mutation,
p.Pro1444Aspfs*106, OI type I; (7) c.4338dupC, duplication,
frameshift mutation, p.Val1447Argfs*104, OI type IB; (8)
c.4343G>A, substitution, missense mutation, p.Gly1448Asp,
OI type I/IV; (9) c.4358_4362del, deletion, frameshift mu-
tation, p.Glu1453Argfs*96, OI type I; and (10) c.4391T>C,substitution, missense mutation, p.Leu1464Pro, OI type III.
Rugolotto et al [13] reported OI type II in a neonate with
a missense mutation in exon 52 of COL1A1 (T>A,
g.16310AF_017178), which converts the codon 1437 from
leucine (CTG) to glutamine (CAG) along the proa1(I)
carboxyl-terminal peptide. Fuccio et al [14] reported a mis-
sense mutation of c.4292C>T, p.T1432I (Thr_Ile) in exon 52
of COL1A1 in a patient with OI type IV. The present case
was associated with OI type III, which is severe and pro-
gressively deforming with grayish sclerae, DI, short stature,
and moderate deformity at birth [1,5,15]. The severity of
autosomal dominant OI increases in the order of type
I < type IV < type III < type II. OI type II is perinatally
lethal, and type I is mild and nondeforming with no limb
deformity.
The affected living girl in this presentation had upper limb
paralysis at birth, mimicking shoulder dislocation or sublux-
ation, birth trauma of the upper limbs, brachial plexus injury
and clavicle fractures. OI may be undetected prenatally, and
the postnatal manifestations may be mistaken as birth trauma.
Rapid diagnosis of OI after birth is necessary for proper pe-
diatric management and parental counseling, to avoid medical
legal problems under such a circumstance. Recent studies have
suggested that cesarean delivery might not protect against
fractures in infants with OI, and whenever vaginal delivery is
chosen, instrumentation should be minimized to avoid intra-
cranial trauma of the affected fetuses [16].
The peculiar aspect of the present case is the recurrence of
autosomal dominant OI in the offspring of unaffected parents
with paternal gonadal mosaicism. Genetic counseling of
recurrent autosomal dominant OI should include a thorough
mutational analysis of the family members, and mutational
analysis of the sperm may detect paternal gonadal mosaicism
for the mutation. It has been suggested that in familial auto-
somal dominant OI with one affected parent, the recurrent risk
is 50%; in the presence of carriers of an autosomal recessive
mutation in both parents, the recurrent risk is 25%; in the case
of parental mosaicism, the recurrent risk for autosomal dom-
inant OI is variable, but can be up to 50%; in the case of
unaffected parents with parental gonadal mosaicism, the
empirical risk of recurrence ranges from 1% to 3%; and in the
absence of parental somatic mosaicism, gonadal mosaicism, or
recessive or dominant inheritance, the recurrent risk is prob-
ably <1% [17e21].
In summary, we present prenatal diagnosis of recurrent
autosomal dominant OI associated with a mutation in the
COL1A1 gene arising from paternal gonadal mosaicism in the
unaffected father. Our case adds to the examples of recurrent
autosomal dominant OI caused by paternal gonadal mosaicism
for a mutation in the COL1A1 gene.
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